PCM
BMRA icon

Penn Capital Management’s Biomerica BMRA Stock Holding History

Penn Capital Management’s Portfolio BMRA Stock Details BMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-2,574
Closed -$6.75K – 150
2024
Q3 		$6.75K Sell
2,574
-39
-1% -$112 ﹤0.01% 146
2024
Q2 		$9.19K Hold
2,613
– – ﹤0.01% 144
2024
Q1 		$17.4K Hold
2,613
– – ﹤0.01% 144
2023
Q4 		$26.1K Sell
2,613
-603
-19% -$4.56K ﹤0.01% 145
2023
Q3 		$22.1K Sell
3,216
-18
-0.6% -$178 ﹤0.01% 150
2023
Q2 		$35.2K Sell
3,234
-125
-4% -$1.48K ﹤0.01% 145
2023
Q1 		$50.3K Buy
+3,359
New +$72.4K 0.01% 154

Other funds holding BMRA

GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Penn Capital Management's BMRA Position: Q4 2024 in Review

Penn Capital Management sold out of Biomerica (BMRA) in Q4 2024, closing a stake of 2,574 shares — an estimated $6.75K sold.

Penn Capital Management first reported a position in BMRA in Q1 2023 and held it in 7 quarters. The position peaked at $50.3K in Q1 2023. 21 funds tracked by Wall St. Rank hold BMRA as of Q4 2024.

  • Penn Capital Management reported no remaining Biomerica position as of Q4 2024 after selling out during the quarter.
  • Penn Capital Management sold 2,574 Biomerica shares in Q4 2024, an estimated $6.75K.
  • Penn Capital Management first reported a position in Biomerica in Q1 2023 and held it in 7 quarters.
  • Penn Capital Management's Biomerica position peaked at $50.3K in Q1 2023.
  • 21 funds tracked by Wall St. Rank held Biomerica as of Q4 2024.

Based on Penn Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.